D. Tilki

发表

Critical analysis of a simplified Fuhrman grading scheme for prediction of cancer specific mortality in patients with clear cell renal cell carcinoma--Impact on prognosis.

C. Meyer, F. Chun, R. Zigeuner, 2016, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Impact of COVID-19 on the time to counseling and treatment of prostate cancer.

H. Heinzer, R. Pose, D. K. Filipas, 2024, The aging male : the official journal of the International Society for the Study of the Aging Male.

[Androgen deprivation therapy and cardiovascular morbidity in prostate cancer: a narrative review].

M. von Deimling, S. Shariat, D. Tilki, 2023, Urologie.

Prognostic significance of lymph node count in surgically treated patients with T2-4 stage nonmetastatic adrenocortical carcinoma.

P. Karakiewicz, S. Ahyai, F. Barletta, 2024, Urologic oncology.

EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer-2024 Update. Part I: Screening, Diagnosis, and Local Treatment with Curative Intent.

O. Rouvière, I. Schoots, G. V. van Leenders, 2024, European urology.

Current Standards for Training in Robot-assisted Surgery and Endourology: A Systematic Review.

A. Larcher, E. Liatsikos, N. Buffi, 2024, European urology.

Survival of patients with lymph node versus bone versus visceral metastases according to CHAARTED/LATITUDE criteria in the era of intensified combination therapies for metastatic hormone-sensitive prostate cancer.

S. Banek, B. Hoeh, F. Chun, 2024, The Prostate.

The Effect of Treatment Intensification on Other-Cause Mortality in Clear-Cell Metastatic Renal Cell Carcinoma Patients.

M. Graefen, P. Karakiewicz, S. Ahyai, 2023, Clinical genitourinary cancer.

Introducing PIONEER: a project to harness big data in prostate cancer 2 research

C. Auffray, D. Lancet, C. Reich, 2019 .

Intraoperative technologies to assess margin status during radical prostatectomy - a narrative review.

O. Windisch, D. Tilki, A. Martini, 2024, Prostate cancer and prostatic diseases.

Influence of Tumor Characteristics and Time to Metastatic Disease on Oncological Outcomes in Metachronous Metastatic Prostate Cancer Patients.

S. Banek, B. Hoeh, C. Cano Garcia, 2024, Clinical genitourinary cancer.

Robot-assisted vs open retropubic radical prostatectomy: a propensity score-matched comparative analysis based on 15 years and 18,805 patients

H. Heinzer, U. Michl, L. Budäus, 2024, World journal of urology.

Contemporary Treatment Patterns and Oncological Outcomes of Metastatic Hormone-sensitive Prostate Cancer and First- to Sixth- line Metastatic Castration-resistant Prostate Cancer Patients

P. Mandel, S. Banek, B. Hoeh, 2024, European urology open science.

External Validation of Stockholm3 in a Retrospective German Clinical Cohort.

D. Tilki, A. Haese, M. Graefen, 2024, European urology focus.

Radical Prostatectomy for Nonmetastatic Prostate Cancer in Renal Transplant Recipients: Outcomes for a Large Contemporary Cohort and a Matched Comparison to Patients Without a Transplant.

C. Lebacle, V. Kasivisvanathan, F. Barletta, 2024, European urology focus.

Improved Survival in Contemporary Community-Based Patients With Metastatic Clear-Cell Renal Cell Carcinoma Undergoing Active Treatment.

M. Graefen, P. Karakiewicz, S. Ahyai, 2024, Journal of the National Comprehensive Cancer Network : JNCCN.

Synthesis and new DNA targeting activity of 6- and 7-tert-butylfascaplysins

M. Graefen, M. Zhidkov, S. Dyshlovoy, 2024, Scientific Reports.

Management of Patients with Advanced Prostate Cancer. Report from the 2024 Advanced Prostate Cancer Consensus Conference (APCCC).

H. Beltran, M. Matikainen, N. Fossati, 2024, European urology.

De-Escalation of Therapy for Prostate Cancer.

T. Esen, B. Esen, U. Selek, 2024, American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting.